Home/Filings/4/0001225208-25-003076
4//SEC Filing

Denton David M 4

Accession 0001225208-25-003076

CIK 0000078003other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 1:58 PM ET

Size

11.8 KB

Accession

0001225208-25-003076

Insider Transaction Report

Form 4
Period: 2025-03-04
Denton David M
Chief Financial Officer & EVP
Transactions
  • Award

    Stock Appreciation Rights

    2025-03-04+413,138413,138 total
    Exercise: $25.75From: 2030-03-04Exp: 2030-03-04Common Stock (413,138 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001428718

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 1:58 PM ET
Size
11.8 KB